Failure of buspirone and verapamil to improve spasmodic torticollis

D. Naber, D. R. Weinberger, M. Gillespie, T. N. Chase

Research output: Contribution to journalArticlepeer-review


The effects of buspirone and verapamil on spasmodic torticollis were investigated in two double-blind, placebo-controlled crossover studies. Buspirone was given in doses of 20-100 mg/day for 4 weeks to 14 patients; verapamil was given in doses of 40-100 mg/day for 3 weeks to 8 patients. Neither drug improved symptoms of the movement disorder (posture, motility, rigidity, tremor), pain, perceived stress, or mood, either in the whole group or in any individual patient.

Original languageEnglish (US)
Pages (from-to)82-84
Number of pages3
JournalJournal of Neuropsychiatry and Clinical Neurosciences
Issue number1
StatePublished - Jan 1 1992
Externally publishedYes

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health


Dive into the research topics of 'Failure of buspirone and verapamil to improve spasmodic torticollis'. Together they form a unique fingerprint.

Cite this